Literature DB >> 1332396

Diagnosis and treatment control of choroidal melanomas--the role of B-scan and Doppler-technique.

R Guthoff1, P Winkler, K Helmke, R Berger.   

Abstract

B-scan guided pulsed Doppler ultrasonography was applied in 62 patients with unilateral malignant melanoma. Prior to radiotherapy Doppler frequency shifts were detected in all but one neoplasm. The average systolic tumour blood flow velocity was recorded as 18.8 +/- 7.6 cm/s. Frequency shifts after radiotherapy are described. Probably the methods will find a place in the evaluation of indeterminate fundus lesions and in the follow-up of irradiated ocular melanomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332396     DOI: 10.1111/j.1755-3768.1992.tb04926.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl


  5 in total

1.  First experience with a new echographic contrast agent.

Authors:  G Cennamo; N Rosa; G F Vallone; F Smaltino
Journal:  Br J Ophthalmol       Date:  1994-11       Impact factor: 4.638

2.  Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging.

Authors:  Bruce M Buerk; Jose S Pulido; Ignacio Chiong; Robert Folberg; Deepak P Edward; Mark T Duffy; Keith R Thulborn
Journal:  Trans Am Ophthalmol Soc       Date:  2004

3.  Experimental differentiation of intraocular masses using ultrahigh-field magnetic resonance imaging--a case series.

Authors:  Karen Falke; Paul Krüger; Norbert Hosten; Annette Zimpfer; Rudolf Guthoff; Sönke Langner; Oliver Stachs
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

4.  Investigation into the quantitative and qualitative characteristics of choroidal melanoma through magnetic resonance imaging and B-scan ultrasound.

Authors:  Vassilis Papayiannis; Konstantinos T Tsaousis; Constantinos A Kouskouras; Afroditi Haritanti; Vasilios F Diakonis; Ioannis T Tsinopoulos
Journal:  Clin Ophthalmol       Date:  2017-08-22

5.  Evaluation of Choroidal Melanoma Vascularization by Color Doppler Flow Imaging: An Option for Follow-Up Tumor Control Assessment after CyberKnife®?

Authors:  Cinja Kaak; Vinodh Kakkassery; Björn O Scheef; Marco Zschoche; Felix Rommel; Guido Hildebrandt; Steffen Emmert; Christian Junghanß; Rudolf F Guthoff; Anselm M Jünemann; Uwe Walter
Journal:  Medicina (Kaunas)       Date:  2021-05-31       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.